Sisram Medical Delivers Solid 2026 Interim Results

Source: PRNewswire· August 19, 2026

Injectables Business Fuels Rapid Growth as APAC Drives International Revenue Expansion HONG KONG, Aug. 19, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a …

This story was reported by PRNewswire. Read the full original article:
Read on PRNewswire

More in Business & Funding

View all